Table 4.
Treatments for AKI and NAKI patient cohorts
| Patients, No. (%) | |||
|---|---|---|---|
| NAKI (n = 721) | HAKI (n = 308) | p value | |
| Invasive mechanical ventilation | 17 (2.4%) | 99 (32.1%) | < 0.001 |
| Noninvasive mechanical ventilation | 30 (4.2%) | 37 (12.0%) | 0.006 |
| Anticoagulants | |||
| Prophylactic | 212 (29.4%) | 153 (49.7%) | < 0.001 |
| Therapeutic | 59 (8.2%) | 86 (27.9%) | 0.002 |
| Steroids | 69 (9.6%) | 99 (32.1%) | 0.006 |
| Dialysis | |||
| CRRT dialysis | 0 | 5 (1.6%) | |
| Hemodialysis | 0 | 29 (9.4%) | |
| CRRT dialysis and hemodialysis | 0 | 16 (5.2%) | |
Group comparison of categorical variables in frequencies and percentages used χ2 test or Fisher exact tests
CRRT continuous renal replacement therapy